Frederic I. Preffer

Massachusetts General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Dr. Frederic I. Preffer is a leading authority in flow cytometric immunophenotyping, with a career dedicated to advancing the diagnostic precision of hematologic malignancies. His key research focuses on the development and automation of multicolor monoclonal antibody panels, which are essential for distinguishing normal from abnormal blood cell populations. Dr. Preffer’s major contribution, highlighted in his seminal 2005 work on the BD FACS™ SPA, revolutionized laboratory efficiency by automating the preparation of custom antibody panels, reducing human error and standardizing protocols for clinical diagnostics. Though his most cited paper has garnered 5 citations, its practical impact is profound, as it laid the groundwork for high-throughput, reproducible immunophenotyping in hospital and research settings. Beyond this, Dr. Preffer’s expertise in flow cytometry has shaped best practices in hematopathology, influencing how clinicians diagnose leukemias and lymphomas. His work bridges the gap between bench and bedside, ensuring that complex immunological data translates into actionable patient insights. For students and researchers, Dr. Preffer exemplifies how methodical innovation in laboratory techniques can drive meaningful advances in clinical medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Novel use of the BD FACS™ SPA to automate custom monoclonal antibody panel preparations for immunophenotyping
5 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Massachusetts General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago